CHENNAI – 10 Nov, 2026 The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has capped trade margins on the Maximum Retail Price (MRP) of 137 anti-cancer drugs, based on the recommendations of an Expert Committee constituted by the Directorate General of Health Services (DGHS), Ministry of Health & Family Welfare, on 17th October, 2026. The revised MRPs of these medicines come into effect from today, 9th November, 2026.
As on 8th of November, 2026, 85 Pharmaceutical Companies have reported revised MRPs for 1,364 anti-cancer formulations, covering 121 drugs. With 679 brands reporting price reductions of more than 50%. The highest reported reduction in MRP is 96.45%. As a result of the price reductions the estimated annual savings to consumers is expected to be ₹3,540.38 crore.
Consumers can check the revised MRP printed on the medicine pack and verify medicine prices through the Pharma Sahi Daam mobile app or NPPA website ( nppa.gov.in ). No chemist or hospital pharmacy can charge more than the revised MRP. In case of overcharging or any other pricing-related complaint, consumers can register their grievance through the Pharma Jan Samadhan portal or contact the NPPA helpline at 1800-111-255.